Romain C. T.
- Country
- France
- Department
- Hematology
Research Overview
Data & Insights
Has run more than one trial at 0 of 56 partner sites.
Specializations
Hematologic Malignancies
The investigator concentrates on cancers of the blood and marrow, spanning acute leukemias, chronic proliferative disorders, and lymphoid neoplasms.
- Acute Myeloid Leukemia
- Acute Lymphoblastic Leukemia
- Peripheral T‑cell Lymphoma
- Multiple Myeloma
- Philadelphia‑negative Myeloproliferative Neoplasms
Research emphasizes integration of transplantation, targeted agents, and novel immunotherapies to improve disease‑free survival.
Solid Tumor Oncology
His work addresses major solid cancers, focusing on advanced disease management and multimodal therapeutic strategies.
- Non‑Small Cell Lung Cancer
- Triple‑Negative Breast Cancer
- Renal Cell Carcinoma
- Hepatocellular Carcinoma
- Osteosarcoma
- Ewing Sarcoma
Efforts include optimizing systemic regimens, radiotherapy integration, and precision medicine approaches.
Infectious Diseases
He investigates a range of bacterial, viral, and parasitic infections, emphasizing therapeutic innovation for resistant and emerging pathogens.
- Nontuberculous Mycobacterial lung infection
- Chikungunya virus disease
- Monkeypox virus disease
- HIV/HBV co‑infection
- Early syphilis
Projects target antiviral prophylaxis, novel antimicrobial delivery, and host‑directed therapies.
Autoimmune and Inflammatory Disorders
His portfolio includes chronic immune‑mediated conditions where modulation of cytokine pathways is central.
- Systemic Lupus Erythematosus
- Atopic Dermatitis
- Vitiligo
- Plaque Psoriasis
- Moderate‑to‑Severe Systemic Lupus
Research explores biologic agents, small‑molecule inhibitors, and combination regimens to achieve durable remission.
Pediatric Neuro‑Oncology
He is engaged in the treatment of primary brain tumors and neuroblastoma in children and adolescents, focusing on molecularly guided therapies.
- Diffuse Intrinsic Pontine Glioma
- Medulloblastoma
- Ependymoma
- Neuroblastoma
Initiatives combine targeted agents, immunotherapy, and advanced radiation techniques to improve survival while limiting toxicity.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.